News
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
Weight-loss jab Mounjaro helps people shed much more weight than rival – study - Mounjaro (tirzepatide) and Wegovy ...
Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results